You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



Simulation Challenge in Diagnosing and Treating Hematologic Malignancies

  • Authors: Shaji K. Kumar, MD; Saad Zafar Usmani, MD, MBA, FACP
  • CME Released: 11/19/2022
  • Valid for credit through: 11/19/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for hematologists/oncologists, nurse practitioners, physician assistants, and other clinicians engaged in the care of patients with hematologic malignancies.

The goal of this activity is that learners will be better able to improve the performance of community-based providers as part of the oncology team regarding personalizing treatment for patients with hematologic malignancies.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Risk-stratifying a patient newly diagnosed with multiple myeloma (MM)
    • Identifying when a patient with MM has relapsed
    • Personalizing treatment for patients with newly diagnosed and relapsed MM
    • Ordering appropriate supportive care/follow-up for patients with MM who are on treatment


  • Shaji K. Kumar, MD

    Professor of Medicine
    Mayo Clinic
    Rochester, MN


    Shaji Kumar, MD, has the following relevant financial relationships:
    Consultant or advisor for: Abbvie; Amgen; Antengene; ArcellX; AstraZeneca; Beigene; Bluebird Bio; Bristol Myers Squibb; Epizyme; GLH Pharma; Janssen; K36; Loxo Oncology; Monterosa Therapeutics; Oncopeptides; Roche-Genentech; Sanofi; Secura Biotherapeutics; Takeda; Trillium
    Research funding from: AbbVie; Allogene; Amgen; AstraZeneca; Bristol Myers Squibb; Carsgen; GlaxoSmithKline; Janssen; Molecular Templates; Novartis; Regeneron; Roche-Genentech; Takeda

  • Saad Zafar Usmani, MD, MBA, FACP

    Chief of Myeloma Service
    Memorial Sloan Kettering Cancer Center
    New York, NY


    Saad Usmani, MD, MBA, FACP, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Bristol Myers Squibb; Celgene; EdoPharma; Genentech; Gilead; GlaxoSmithKline; Janssen; Oncopeptides; Sanofi; Seagen LLC; SecuraBio; SkylineDX; Takeda; TeneoBio
    Speaker or member of speakers bureau for: Amgen; Bristol Myers Squibb; Janssen; Sanofi
    Research funding from: Amgen; Array Biopharma; Bristol Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Merck; Pharmacyclics; Sanofi; Seagen LLC; SkylineDX; Takeda


  • Stephanie Baumhover, PharmD, BCPS

    Medical Education Director, MedSims


    Stephanie Baumhover, PharmD, BCPS, has no relevant financial relationships.

  • Terra Sumstine

    Writer, Chichester Associates Inc


    Terra Sumstine has no relevant financial relationships.

Course Director

  • Sagar Lonial MD, FACP

    Chair and Professor
    Department of Hematology and Medical Oncology
    Anne and Bernard Gray Family Chair in Cancer
    Chief Medical Officer
    Winship Cancer Institute
    Emory University School of Medicine


    The opinions expressed are those of Dr Lonial and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Lonial’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare. Sagar Lonial, MD, FACP, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Bristol Myers Squibb Company; Celgene; Genentech; GlaxoSmithKline; Janssen; Novartis; Takeda
    Research funding from: Bristol Myers Squibb Company; Janssen; Novartis; Takeda
    Other: Board of director for: TG Therapeutics 

Compliance Reviewer

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

Developed through a partnership between Medscape and Emory.


    For Physicians

  • This activity has been planned and implemented in accordance with the Essential Areas and Polices of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Emory University School of Medicine and the Southeastern Angiographic Society. The Emory University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    The Emory University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Simulation Challenge in Diagnosing and Treating Hematologic Malignancies

Authors: Shaji K. Kumar, MD; Saad Zafar Usmani, MD, MBA, FACPFaculty and Disclosures

CME Released: 11/19/2022

Valid for credit through: 11/19/2023, 11:59 PM EST



Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

patient simulation
  • Print